Approval · Notice of Compliance 18681 · 2016
PEGETRON: Notice of Compliance 18681
Issued November 22, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18681
- Date
- November 22, 2016
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the product monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PEGETRON | Not yet assigned | — |
| PEGETRON (CLEARCLICK/REDIPEN) | Not yet assigned | — |
Medicinal ingredients
- RIBAVIRIN 200 MG per CAP
- PEGINTERFERON ALFA-2B 50 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 150 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 80 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 100 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 120 MCG per 0.5ML